Evidence map›Paper›PMID 39712285›Full record

ArticleInternational journal of cardiology. Congenital heart disease2022

Association of plasma biomarkers and interstitial myocardial fibrosis in fontan population: A machine learning approach.

Vien T Truong, Ryan A Moore, Adam M Lubert, Michael D Taylor, Wojciech Mazur, Tarek Alsaied, Bryan H Goldstein

Abstract read
In one paragraph

Article in International journal of cardiology. Congenital heart disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Recent advances in biomarkers for cardiac fibrosis.Frontiers in cardiovascular medicine · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vien T TruongThe Christ Hospital Health Network, Cincinnati, OH, USA.
Ryan A MooreThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Adam M LubertThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Michael D TaylorThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Wojciech MazurThe Christ Hospital Health Network, Cincinnati, OH, USA.
Tarek AlsaiedThe Heart Institute, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Bryan H GoldsteinThe Heart Institute, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Myocardial fibrosis is a common final pathway in many myocardial diseases. Circulating biomarkers are recognized in heart failure management as potential treatment targets. The current study sought to evaluate the association between biomarkers of myocardial fibrosis and myocardial fibrosis using machine learning techniques. Methods and Results: The permutation-based feature importance and the cooperation network among important features in random forest algorithm were applied to evaluate the relationship of each biomarker to extracellular volume fraction (ECV). A total of 25 Fontan patients were included in the study with multiple serum biomarkers obtained at the time of CMR. The mean age at the time of assessment was 16.3 ± 6.8 years with the mean duration of Fontan circulation of 13.0 ± 6.3 years. Lateral tunnel was the most common Fontan type (52%), and the majority (72%) had a systemic left ventricle. The mean ECV was 28 ± 5%. Among different types of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP), our study found that MMP-10, and TIMP-1 were the most strongly associated with cardiac fibrosis measured by ECV. Conclusions: TIMP-1 and MMP-10 are circulating biomarkers that may represent promising targets for the prevention and treatment of myocardial fibrosis in Fontan circulation.

Indexed as

BiomarkerFontanMachine learningMyocardial fibrosis

Identifiers

PMID39712285
PMCPMC11657535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.